Daliresp® Roflumilast 500 mcg Tablets for COPD Treatment - 90 Count Bottle

Name: Daliresp® Roflumilast 500 mcg Tablets for COPD Treatment - 90 Count Bottle
Brand: AstraZeneca Pharmaceuticals
SKU: USAMP#38224325

USAMP#38224325SKU: 00310009590Daliresp®

License Required

Product Spotlight

Contains 500 mcg of Roflumilast, a potent Phosphodiesterase Type 4 Inhibitor.
Manufactured by AstraZeneca Pharmaceuticals, ensuring high-quality medication.
Prescription-only medication designed for the management of symptoms associated with Chronic Obstructive Pulmonary Disease (COPD).
Comes in a bottle of 90 tablets, providing a comprehensive treatment course.
Formulated without latex, making it suitable for individuals with latex allergies.
Specifically targets inflammation and bronchoconstriction in COPD patients, improving lung function and reducing exacerbations.

Contains 500 mcg of Roflumilast, a potent Phosphodiesterase Type 4 Inhibitor.
Manufactured by AstraZeneca Pharmaceuticals, ensuring high-quality medication.
Prescription-only medication designed for the management of symptoms associated with Chronic Obstructive Pulmonary Disease (COPD).
Comes in a bottle of 90 tablets, providing a comprehensive treatment course.
Formulated without latex, making it suitable for individuals with latex allergies.
Specifically targets inflammation and bronchoconstriction in COPD patients, improving lung function and reducing exacerbations.